Simufilam (PTI-125), 100 mg, for Mild-to-moderate Alzheimer's Disease Patients
Clinical trial NCT04388254 · COMPLETED
Trial details
- NCT number
- NCT04388254
- Sponsor
- Cassava Sciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-24
- Primary completion
- 2023-11-09
- Enrollment
- 220
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.